
Hormone data is becoming beauty data
In 2026, money began flowing into continuous hormone tracking: a wrist wearable from Clair Health that monitors oestrogen, progesterone, LH and FSH, a €40 million grant challenge from SPRIND and Ida Tin, and new menopause and women's-health features from Apple and Oura (BeautyMatter, 2026). The beauty logic is simple. Hormones affect oil, pigment, barrier, sleep and mood, so hormone data looks like skin data.
Some of that is true. Some of it will be sold well ahead of the evidence. The useful question is which is which.
What hormones really do to skin
Puberty. Apocrine sweat glands are present from birth but only start secreting at puberty, and they are generally regarded as the glands behind body odour (Baker, 2019). Odour care is, in effect, a puberty-onward category.
Pregnancy. Melasma affects between 36.4% and 75% of pregnant women in published studies, and up to 30% of cases persist after delivery (Zhao et al., 2024). In melanin-rich skin, which marks easily, gentle routes matter even more.
Menopause. Skin collagen is thought to fall by as much as 30% in the first five years after menopause, with skin thickness falling about 1.13% and collagen content about 2% per postmenopausal year (reviewed in Thornton, 2013). In a large US survey, 36.2% of postmenopausal women had dry skin (Dunn et al., 1997).
Life stages are visible and well documented. Day-by-day cycle effects on skin are small, inconsistent and untested as a basis for products.
Where the evidence stops
The menstrual cycle does affect skin, but the measurements disagree. One study found more water loss through the skin when oestrogen and progesterone were lowest (Harvell et al., 1992); another, smaller one found no significant effect of the cycle on barrier function (Berardesca et al., 1996). We found no controlled trial showing that timing skincare actives to cycle phase improves outcomes.
That does not make cycle awareness useless. People notice changes in their skin, and good care responds to what they notice. But a product that promises results because it is cycle-synced is making a claim nobody has tested.
What we think good life-stage care looks like
- Design for life stages people can see. Puberty odour, pregnancy pigmentation, menopausal dryness and thinning are real, common and measurable.
- Gentle first. Especially for pigmentation in pregnancy and on melanin-rich skin, where irritation can make marks worse.
- Respond to the person, not the calendar. Track what the skin is doing, not a predicted hormone curve.
- No hormone claims without hormone evidence. A claim that a product works with someone's hormones needs a study that measured it.
- Treat hormone data as health data. If beauty ever uses it, it deserves medical-grade privacy and consent.
Anadoris Biotech has no results in this area. These are the standards we will hold our own life-stage research to.
Questions
Does cycle-synced skincare work?
There is no controlled evidence that timing skincare actives to the menstrual cycle improves results. Studies of how the cycle affects the skin barrier disagree with each other.
How does menopause change skin?
Collagen and skin thickness fall in the years after menopause, and dryness is common. A widely cited review estimates collagen falls by as much as 30% in the first five years.
Why is melasma common in pregnancy?
Hormonal changes in pregnancy stimulate pigment production. Published studies report melasma in roughly a third to three-quarters of pregnant women, and some cases persist after delivery.
Sources
- BeautyMatter (8 Sep 2026). Hormone Intelligence Is Becoming Beauty's Next Data Layer (industry news)
- Baker (2019). Physiology of sweat gland function. Temperature 6(3):211–259
- Zhao, Fu & Cheng (2024). Clinical, Cosmetic and Investigational Dermatology 17:2301–2310 (melasma in pregnancy)
- Thornton (2013). Estrogens and aging skin. Dermato-Endocrinology 5(2):264–270
- Dunn et al. (1997). Does estrogen prevent skin aging? Archives of Dermatology 133:339–342
- Harvell, Hussona-Saeed & Maibach (1992). Contact Dermatitis 27:294–301 (barrier function across the menstrual cycle)
- Berardesca et al. (1996). Skin Research and Technology 2:88–90 (barrier function and the menstrual cycle)
Related
- Research note: uneven tone on melanin-rich skin
- Research area: skin longevity
- Research note: body odour and the skin microbiome
A perspective is an argument, not a study. Figures are from the sources listed, which are not Anadoris studies. Anadoris Biotech’s research is at the exploration stage: no Anadoris results or product claims are made here.